The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990–2019

Background Colorectal cancer (CRC) is among the five most incident and lethal cancers in world and its burden varies between countries and sexes. We aimed to present a comprehensive measure called the quality of care index (QCI) to evaluate the inequity and healthcare quality of care regarding CRC by sex and location. Methods Data on the burden of CRC were extracted from the Global Burden of Disease study 2019. It was transformed to four ratios, including mortality-to-incidence, disability-adjusted life years (DALYs)-to-prevalence, prevalence-to-incidence, and years of life lost (YLLs)-to-years lived with disability (YLDs). Principal component analysis was implemented on the four ratios and the most influential component was considered as QCI with a score ranging from zero to 100, for which higher scores represented better quality of care. Gender Disparity Ratio (GDR) was calculated by dividing QCI for females by males. Results The global incidence and death numbers of CRC were 2,166,168 (95% uncertainty interval: 1,996,298–2,342,842) and 1,085,797 (1,002,795–1,149,679) in 2019, respectively. Globally, QCI and GDR values were 77.6 and 1.0 respectively in 2019. There was a positive association between the level of quality of care and socio-demographic index (SDI) quintiles. Region of the Americas and African Region had the highest and lowest QCI values, respectively (84.4 vs. 23.6). The QCI values started decreasing beyond the age of 75 in 2019 worldwide. Conclusion There is heterogeneity in QCI between SDI quintiles. More attention should be paid to people aged more than 75 years old because of the lower quality of care in this group.

[1]  F. Farzadfar,et al.  Global, regional, and national survey on the burden and quality of care of pancreatic cancer: a systematic analysis for the Global Burden of Disease study 1990-2017. , 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[2]  F. Farzadfar,et al.  Global, regional, and national quality of care of ischaemic heart disease from 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017. , 2021, European journal of preventive cardiology.

[3]  H. Gharib,et al.  Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017 , 2021, Cancer medicine.

[4]  F. Farzadfar,et al.  A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017 , 2021, PloS one.

[5]  F. Farzadfar,et al.  A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017 , 2021, Experimental Hematology & Oncology.

[6]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[7]  V. S. Gordeev,et al.  Iran health insurance system in transition: equity concerns and steps to achieve universal health coverage , 2021, International Journal for Equity in Health.

[8]  Dan J Stein,et al.  Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[9]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[10]  Jacob L. Stubbs,et al.  Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 , 2020, The Lancet.

[11]  Ravensara S. Travillian,et al.  Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, The Lancet.

[12]  Chyke A Doubeni,et al.  Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies. , 2020, Gastroenterology.

[13]  T. H. Nguyen,et al.  The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.

[14]  Susan Hutfless,et al.  The hidden cost of colonoscopy including cost of reprocessing and infection rate: the implications for disposable colonoscopes , 2019, Gut.

[15]  F. Bray,et al.  Global trends in colorectal cancer mortality: projections to the year 2035 , 2019, International journal of cancer.

[16]  Reza Ghadimi Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[17]  Mohammad Hosein Farzaei,et al.  Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[18]  Joshua T. Cohen,et al.  Cost-effectiveness of colorectal cancer screening in Ukraine , 2018, Cost Effectiveness and Resource Allocation.

[19]  Ronan A Lyons,et al.  Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 , 2018, The Lancet.

[20]  Sheila Leatherman,et al.  Delivering Quality Health Services: A Global Imperative for Universal Health Coverage , 2018 .

[21]  M. Vatn,et al.  Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men , 2018, Annals of Internal Medicine.

[22]  C. Hamashima,et al.  Association between age factors and strategies for promoting participation in gastric and colorectal cancer screenings , 2018, BMC Cancer.

[23]  M. Ebell,et al.  Cancer screening recommendations: an international comparison of high income countries , 2018, Public Health Reviews.

[24]  R. West Tobacco smoking: Health impact, prevalence, correlates and interventions , 2017, Psychology & health.

[25]  T. Vos,et al.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.

[26]  S. Karanth,et al.  Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates – A Modeling Study , 2016, PloS one.

[27]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[28]  M. Phipps,et al.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[29]  Y. Sano,et al.  Colorectal cancer screening of the general population in East Asia , 2016, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[30]  Jung Eun Lee,et al.  Sex- and gender-specific disparities in colorectal cancer risk. , 2015, World journal of gastroenterology.

[31]  W. Cheung,et al.  Sex-based Disparities in Colorectal Cancer Screening , 2014, American journal of clinical oncology.

[32]  B. Olivan,et al.  Age differences in presentation, diagnosis pathway and management of colorectal cancer. , 2014, Cancer epidemiology.

[33]  M. Tinetti,et al.  Age-based and Sex-based Disparities in Screening Colonoscopy Use Among Medicare Beneficiaries , 2013, Journal of clinical gastroenterology.

[34]  Constance M. Johnson,et al.  Meta-analyses of colorectal cancer risk factors , 2013, Cancer Causes & Control.

[35]  Miguel Martín,et al.  Differences in the therapeutic approach to colorectal cancer in young and elderly patients. , 2012, The oncologist.

[36]  G. Koh,et al.  Socioeconomic factors affecting colorectal, breast and cervical cancer screening in an Asian urban low-income setting at baseline and post-intervention. , 2012, Preventive medicine.

[37]  Hanlin L. Wang,et al.  Colorectal carcinoma: Pathologic aspects. , 2012, Journal of gastrointestinal oncology.

[38]  Esteve Fernandez,et al.  Sex differences in hospital readmission among colorectal cancer patients , 2005, Journal of Epidemiology and Community Health.

[39]  E. van Doorslaer,et al.  On the interpretation of a concentration index of inequality. , 2004, Health economics.

[40]  R. Stott,et al.  The World Bank , 2008, Annals of tropical medicine and parasitology.

[41]  E. Smith Methods of Multivariate Analysis , 1997 .

[42]  A. Wagstaff,et al.  On the measurement of horizontal inequity in the delivery of health care. , 1991, Journal of health economics.

[43]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[44]  C. Daniel,et al.  Colorectal cancer disparities beyond biology: Screening, treatment, access. , 2017, Frontiers in bioscience.

[45]  Mimi C. Yu,et al.  Cancer, Culture, and Health Disparities: Time to Chart a New Course? , 2010, CA: a cancer journal for clinicians.